| http://dbpedia.org/ontology/abstract
|
Abivax SA is a French clinical-stage, publ … Abivax SA is a French clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer. The company is headquartered in Paris, France and closely cooperates with the CNRS Collaborative Laboratory in Montpellier, France.orative Laboratory in Montpellier, France.
, Abivax est une société de biotechnologie c … Abivax est une société de biotechnologie cotée à la bourse de Paris. Ses recherches et essais cliniques exploitent le système immunitaire afin de développer des nouveaux traitements contre les maladies inflammatoires, les maladies virales et le cancer. La société est basée à Paris et coopère étroitement avec le laboratoire collaboratif du CNRS à Montpellier.atoire collaboratif du CNRS à Montpellier.
|
| http://dbpedia.org/ontology/foundingDate
|
"2013-12-04"^^xsd:date
|
| http://dbpedia.org/ontology/foundingYear
|
2013
|
| http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/Paris +
|
| http://dbpedia.org/ontology/locationCountry
|
http://dbpedia.org/resource/France +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
27
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Abivax_logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.abivax.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
59186835
|
| http://dbpedia.org/ontology/wikiPageLength
|
13133
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1105561000
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Institut_Curie +
, http://dbpedia.org/resource/Category:Companies_listed_on_Euronext_Paris +
, http://dbpedia.org/resource/French_National_Center_for_Scientific_Research +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_France +
, http://dbpedia.org/resource/Category:2015_initial_public_offerings +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_Paris +
, http://dbpedia.org/resource/CNRS +
, http://dbpedia.org/resource/MD_Anderson_Cancer_Center +
, http://dbpedia.org/resource/Inflammatory_diseases +
, http://dbpedia.org/resource/University_of_Montpellier +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2013 +
, http://dbpedia.org/resource/TNF%CE%B1 +
, http://dbpedia.org/resource/Liver_cancer +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Ulcerative_colitis +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/Montpellier +
, http://dbpedia.org/resource/France +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_France +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/San_Diego +
, http://dbpedia.org/resource/Hepatocellular_carcinoma +
, http://dbpedia.org/resource/Viral_diseases +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Houston +
, http://dbpedia.org/resource/HIV +
, http://dbpedia.org/resource/Category:French_companies_established_in_2013 +
, http://dbpedia.org/resource/Crohn%E2%80%99s_disease +
, http://dbpedia.org/resource/COVID-19 +
, http://dbpedia.org/resource/Paris +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/R&D +
|
| http://dbpedia.org/property/founded
|
"2013-12-04"^^xsd:date
|
| http://dbpedia.org/property/founder
|
Phillipe Pouletty
|
| http://dbpedia.org/property/hqLocationCity
|
http://dbpedia.org/resource/Paris +
|
| http://dbpedia.org/property/hqLocationCountry
|
http://dbpedia.org/resource/France +
|
| http://dbpedia.org/property/keyPeople
|
Hartmut Ehrlich
|
| http://dbpedia.org/property/logo
|
Abivax logo.png
|
| http://dbpedia.org/property/name
|
Abivax SA
|
| http://dbpedia.org/property/numEmployees
|
27
|
| http://dbpedia.org/property/tradedAs
|
Euronext:ABVX
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/website
|
https://www.abivax.com/ +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_France +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:Companies_based_in_Paris +
, http://dbpedia.org/resource/Category:Companies_listed_on_Euronext_Paris +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:French_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_France +
, http://dbpedia.org/resource/Category:2015_initial_public_offerings +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Abivax?oldid=1105561000&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Abivax_logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.abivax.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Abivax +
|
| http://xmlns.com/foaf/0.1/name
|
Abivax SA
|
| owl:sameAs |
http://fa.dbpedia.org/resource/%D8%A2%D8%A8%DB%8C%D9%88%DA%A9%D8%B3 +
, https://global.dbpedia.org/id/2oibE +
, http://fr.dbpedia.org/resource/Abivax +
, http://www.wikidata.org/entity/Q30268737 +
, http://dbpedia.org/resource/Abivax +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
Abivax est une société de biotechnologie c … Abivax est une société de biotechnologie cotée à la bourse de Paris. Ses recherches et essais cliniques exploitent le système immunitaire afin de développer des nouveaux traitements contre les maladies inflammatoires, les maladies virales et le cancer. La société est basée à Paris et coopère étroitement avec le laboratoire collaboratif du CNRS à Montpellier.atoire collaboratif du CNRS à Montpellier.
, Abivax SA is a French clinical-stage, publ … Abivax SA is a French clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer. The company is headquartered in Paris, France and closely cooperates with the CNRS Collaborative Laboratory in Montpellier, France.orative Laboratory in Montpellier, France.
|
| rdfs:label |
Abivax
|
